RedHill Biopharma Provides Q3/2020 Results and Highlights, Including 300% Talicia Prescription Growth
Go back to RedHill Biopharma Provides Q3/2020 Results and Highlights, Including 300% Talicia Prescription Growth| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.55 -0.02 (3.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.57 | 52 Week High | $16.54 | |||
| Open | $0.56 | 52 Week Low | $8.10 | |||
| Day High | $0.57 | P/E | N/A | |||
| Day Low | $0.55 | EPS | $0.00 | |||
| Volume | 5,732 | |||||
